Metabolic Syndrome

Metabolic syndrome is a clustering of abnormalities that includes obesity, hyperglycemia, high blood pressure, and atherogenic dyslipidemia. Advances in scientific knowledge, the increasing prevalence of obesity, and the disorder's role in contributing to cardiovascular disease and diabetes are fueling interest in metabolic syndrome.

What is Metabolic Syndrome?

Metabolic syndrome is a condition characterized by the presence diabetes, obesity and high blood pressure. These conditions increase the risk of cardiovascular illnesses such as stroke and heart disease. Individually, diabetes, high blood pressure and obesity can lead to vascular damage, but a combination of these illnesses is particularly dangerous.

History of Metabolic Syndrome

Metabolic Syndrome Risk Factors

Metabolic Syndrome Prevention

Metabolic Syndrome Treatment

Metabolic Syndrome and Bariatric Surgery

Polycystic Ovary Syndrome and Metabolic Syndrome

Abdominal Obesity and the Metabolic Syndrome

Latest Metabolic Syndrome News and Research

The prediabetes paradox: Balancing early intervention and overdiagnosis

Prediabetes, a diagnosis intended to identify high-risk persons and prevent progression to diabetes, has been a topic of ongoing debate, and experts continue to disagree about its screening criteria, interpretation, and implications.

28 May 2024

Heavy menstrual bleeding raises heart disease risk in young women

Study found that heavy menstrual bleeding (HMB) is linked to increased cardiovascular disease (CVD) risk in young women, even without irregular menstruation.

28 May 2024

Low vitamin D levels linked to higher diabetes risk in older adults, study finds

A meta-analysis found that low serum vitamin D levels significantly increase the risk of developing type 2 diabetes in older adults, even after adjusting for several confounders.

27 May 2024

Mediterranean diet cuts environmental impact and improves metabolic health, study finds

Researchers found that a Mediterranean diet with reduced energy intake significantly reduced environmental impacts, such as acidification, eutrophication, and land use, in individuals with metabolic syndrome. Caloric reduction and diet adherence were key factors mediating these benefits.

27 May 2024

Ketogenic diet improves metabolic and mental health in schizophrenia and bipolar disorder patients, study finds

Researchers found that a ketogenic diet significantly improves both metabolic and psychiatric health in individuals with schizophrenia or bipolar disorder, with notable reductions in weight, waist circumference, and mental illness severity.

27 May 2024

Running therapy matches antidepressants for mental health, surpasses for physical benefits

Researchers found that while both antidepressants and group running therapy effectively improved mental health in patients with anxiety and depression, running therapy had significantly better outcomes for physical health indicators.

26 May 2024

Prenatal exposure to endocrine disruptors linked to poorer metabolic health in childhood

The term 'metabolic syndrome' (MetS) encompasses a group of factors, such as abdominal obesity, hypertension and insulin resistance, that together increase the risk of cardiovascular disease and type 2 diabetes.

23 May 2024

Taurine supplementation shows promise in reducing metabolic syndrome risk factors, study finds

A study in Nutrition & Diabetes meta-analyzed randomized clinical trials and found that taurine supplementation significantly reduces key risk factors for metabolic syndrome, such as high blood pressure, fasting blood glucose, and triglycerides, with no notable adverse effects.

20 May 2024

Body fat percentage beats BMI in predicting obesity-related health risks, study says

A study in the Journal of Clinical Endocrinology & Metabolism found that body fat percentage (%BF) thresholds are more accurate than BMI for predicting obesity-related health conditions, suggesting new standards for defining overweight and obesity.

19 May 2024

New insights into health challenges and the risk factors driving metabolic syndromes

The latest findings from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, published today in The Lancet, provide new insights into health challenges and the risk factors that are driving them.

17 May 2024

Monell study uncovers dual role of mammalian sweet taste receptor in regulating blood sugar levels

The rich research portfolio of the Monell Chemical Senses Center on sweet taste goes way back: Monell scientists were one of four teams in 2001 that found and described the mammalian sweet taste receptor – TAS1R2-TAS1R3.

17 May 2024

Menthol-derived molecules: promising candidates for anti-inflammatory and anti-obesity therapy

Modified derivatives of natural products have led to significant therapeutic advances and commercial success in recent times.

15 May 2024

Western diet linked to chronic diseases by gut microbiota disruption

The Western diet disrupts gut microbiota and gut barrier function, increasing the risk of non-communicable chronic diseases through chronic low-grade inflammation.

13 May 2024

Obesity, metabolic syndrome impact breast cancer subtypes and mortality

In the Women's Health Initiative (WHI) randomized trial, a low-fat diet reduced breast cancer mortality, especially in women with more metabolic syndrome (MetS) components (obesity, high blood pressure, elevated blood sugar, and abnormal cholesterol).

13 May 2024

Higher consumption of ultra-processed foods linked to elevated mortality risk

The relationship between ultra-processed food (UPF) intake and all-cause and cause-specific death.

9 May 2024

Underdiagnosed and common: Study highlights neuropathy's hidden toll

Neuropathy, the nerve damage that causes pain and numbness in the feet and hands and can eventually lead to falls, infection and even amputation, is very common and underdiagnosed, according to a study published in the May 8, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

8 May 2024